← Back to UTHR

United Therapeutics Corporation financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 06/05/2026Sep 2025Filed 29/10/2025Jun 2025Filed 05/08/2026Mar 2025Filed 06/05/2026Sep 2024Filed 29/10/2025Jun 2024Filed 30/07/2025Mar 2024Filed 30/04/2025
$783$782$800$799$794$749$715$678
$333$275$339$310$322$309$278$307
$7.27$5.82$7.16$6.41$6.63$6.39$5.85$6.17
4647474849484850

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.